{
    "ticker": "EDAP",
    "name": "EDAP TMS S.A.",
    "description": "EDAP TMS S.A. is a global leader in the field of minimally invasive urology treatments and the pioneer of high-intensity focused ultrasound (HIFU) technology for the treatment of prostate cancer. Founded in 2000 and headquartered in Lyon, France, EDAP focuses on developing innovative medical devices and therapeutic solutions to improve patient outcomes and enhance the quality of care. The company offers a range of products, including the Focal One\u00ae system, which integrates ultrasound imaging and HIFU technology for targeted treatment of prostate cancer, as well as the Ablatherm\u00ae system for non-invasive tumor destruction. EDAP's commitment to research and development enables it to continuously innovate and adapt to the evolving healthcare landscape. The company collaborates with numerous medical institutions and professionals worldwide to ensure that its treatments are effective and safe. With a strong emphasis on patient-centric care, EDAP not only seeks to provide advanced medical technologies but also aims to enhance the overall experience of patients undergoing treatment. The company is dedicated to improving the lives of patients and strives to be at the forefront of urological treatment advancements.",
    "industry": [
        "Medical Devices",
        "Healthcare"
    ],
    "headquarters": "Lyon, France",
    "founded": "2000",
    "website": "https://www.edap-tms.com",
    "ceo": "Marc Oczachowski",
    "social_media": {
        "twitter": "https://twitter.com/EDAPTMS",
        "linkedin": "https://www.linkedin.com/company/edap-tms/"
    },
    "investor_relations": "https://www.edap-tms.com/investors/",
    "key_executives": [
        {
            "name": "Marc Oczachowski",
            "position": "CEO"
        },
        {
            "name": "Fran\u00e7ois Dard",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Medical Devices",
            "products": [
                "Focal One\u00ae",
                "Ablatherm\u00ae"
            ]
        }
    ],
    "seo": {
        "meta_title": "EDAP TMS S.A. | Minimally Invasive Urology Treatments",
        "meta_description": "Explore EDAP TMS S.A., a leader in minimally invasive urology treatments and HIFU technology for prostate cancer. Learn about their innovative solutions and commitment to patient care.",
        "keywords": [
            "EDAP",
            "Urology",
            "HIFU",
            "Prostate Cancer Treatment",
            "Minimally Invasive Surgery"
        ]
    },
    "faq": [
        {
            "question": "What does EDAP specialize in?",
            "answer": "EDAP specializes in minimally invasive urology treatments and is a pioneer in HIFU technology for prostate cancer."
        },
        {
            "question": "Who is the CEO of EDAP?",
            "answer": "Marc Oczachowski is the CEO of EDAP TMS S.A."
        },
        {
            "question": "Where is EDAP headquartered?",
            "answer": "EDAP is headquartered in Lyon, France."
        },
        {
            "question": "What are EDAP's main products?",
            "answer": "EDAP's main products include the Focal One\u00ae system and the Ablatherm\u00ae system."
        },
        {
            "question": "When was EDAP founded?",
            "answer": "EDAP was founded in 2000."
        }
    ],
    "competitors": [
        "TMO",
        "BSX",
        "ISRG",
        "MDT"
    ],
    "related_stocks": [
        "JNJ",
        "ABT",
        "BMY",
        "PFE"
    ]
}